Coastlands Capital LP's Form 4 filing
Adial Pharmaceuticals, Inc. (ADIL) · filed Jul 16, 2026
- Accession no.
- 0001104659-26-084300
- Filed
- Jul 16, 2026, 5:08 PM ET
- Trade date
- Jul 14-16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $8.69K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coastlands Capital LPCIK 0002068530 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Common Stock | PPurchaseAcquired | +2,000 | $2.65 | +$5,300 | 387,075 | Indirect | |
| Jul 16, 2026 | Common Stock | PPurchaseAcquired | +1,233 | $2.75 | +$3,390.75 | 388,308 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.